List of Studies ( Metabolite:PE P-40:8 or PE O-40:9)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003266 | AN005350 | Metabolomics analysis of human spermatozoa reveals impaired metabolic pathways in asthenozoospermia | Spermatozoa | Human | University of Aveiro | LC-MS | |
| ST003266 | AN005351 | Metabolomics analysis of human spermatozoa reveals impaired metabolic pathways in asthenozoospermia | Spermatozoa | Human | University of Aveiro | LC-MS | |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS |
